Idaho Technology Becomes BioFire Diagnostics

has changed its corporate name to BioFire Diagnostics, Inc. (Salt Lake City, UT, USA) to more accurately reflect its growing breadth of services in molecular diagnostics. The company also re-launched its website to reveal its new branding.

BioFire Diagnostics will continue to focus on its FilmArray pathogen detection system to develop multiplex diagnostic tests for various clinical applications. The FilmArray Respiratory Panel (RP) is US Food and Drug Administration (FDA; Silver Spring, MD, USA)-cleared for 20 viral and bacterial respiratory pathogens. The company now provides the only FDA-cleared clinical diagnostic test for 8 of the 20 organisms in its panel.

The company is continuing to develop a broader test menu for its FilmArray system, including a blood culture ID panel, gastrointestinal panel, and a meningitis panel. BioFire is also working on reliable and sensitive biosurveillance products such as its polymerase chain reaction (PCR)-based biodetection system RAZOR EX and the FilmArray BioSurveillance system. With over 70 patents related to polymerase chain reaction (PCR), the company has used its extensive patent portfolio to successfully market nearly 200 products to the clinical, research, and military markets.

The diagnostic respiratory panel, FilmArray RP operates on the user-friendly FilmArray system, for hospital-based clinical laboratories in the US and EU.

Kirk Ririe, CEO of BioFire Diagnostics said, "We have established strong momentum in the diagnostics marketplace and the new branding under BioFire Diagnostics better reflects the markets we serve. We believe we are in an excellent position to continue building our business by driving growth of our broad molecular diagnostic product portfolio."

BioFire collaborates with various US governmental agencies including the Department of Health and Human Services and the Department of Defense. Additionally, researchers, medical technicians, law enforcement officers, and soldiers in the field use company devices to detect or study disease-causing organisms.

Related Links:
BioFire Diagnostics, Inc.
US Food and Drug Administration